Comparison of protocols and registry entries to published reports for randomised controlled trials

被引:259
作者
Dwan, Kerry [1 ]
Altman, Douglas G. [2 ]
Cresswell, Lynne [3 ]
Blundell, Michaela [3 ]
Gamble, Carrol L. [3 ]
Williamson, Paula R. [3 ]
机构
[1] Univ Liverpool, Alder Hey Childrens NHS Fdn Trust, Inst Child Hlth, Liverpool L12 2AP, Merseyside, England
[2] Wolfson Coll Annexe, Ctr Stat Med, Oxford, England
[3] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2011年 / 01期
关键词
OUTCOME SELECTION BIAS; CLINICAL-TRIALS; PUBLICATION BIAS; FOLLOW-UP; INDUSTRY; TIME; METAANALYSIS; COMPLETION; GABAPENTIN; COMMITTEE;
D O I
10.1002/14651858.MR000031.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Publication of complete trial results is essential if people are to be able to make well-informed decisions about health care. Selective reporting of randomised controlled trials (RCTs) is a common problem. Objectives To systematically review studies of cohorts of RCTs to compare the content of trial reports with the information contained in their protocols, or entries in a trial registry. Search strategy We conducted electronic searches in Ovid MEDLINE (1950 to August 2010); Ovid EMBASE (1980 to August 2010); ISI Web of Science (1900 to August 2010) and the Cochrane Methodology Register (Issue 3, 2010), checked reference lists, and asked authors of eligible studies to identify further studies. Studies were not excluded based on language of publication or our assessment of their quality. Selection criteria Published or unpublished cohort studies comparing the content of protocols or trial registry entries with published trial reports. Data collection and analysis Data were extracted by two authors independently. Risk of bias in the cohort studies was assessed in relation to follow up and selective reporting of outcomes. Results are presented separately for the comparison of published reports to protocols and trial registry entries. Main results We included 16 studies assessing a median of 54 RCTs (range: 2 to 362). Twelve studies compared protocols to published reports and four compared trial registry entries to published reports. In two studies, eligibility criteria differed between the protocol and publication in 19% and 100% RCTs. In one study, 16% (9/58) of the reports included the same sample size calculation as the protocol. In one study, 6% (4/63) of protocol-report pairs gave conflicting information regarding the method of allocation concealment, and 67% (49/73) of blinded studies reported discrepant information on who was blinded. In one study unacknowledged discrepancies were found for methods of handling protocol deviations (44%; 19/43), missing data (80%; 39/49), primary outcome analyses (60%; 25/42) and adjusted analyses (82%; 23/28). One study found that of 13 protocols specifying subgroup analyses, 12 of these 13 trials reported only some, or none, of these. Two studies found that statistically significant outcomes had a higher odds of being fully reported compared to nonsignificant outcomes (range of odds ratios: 2.4 to 4.7). Across the studies, at least one primary outcome was changed, introduced, or omitted in 4-50% of trial reports. Authors' conclusions Discrepancies between protocols or trial registry entries and trial reports were common, although reasons for these were not discussed in the reports. Full transparency will be possible only when protocols are made publicly available or the quality and extent of information included in trial registries is improved, and trialists explain substantial changes in their reports.
引用
收藏
页数:50
相关论文
共 88 条
[1]   Selective reporting in clinical trials:: analysis of trial protocols accepted by The Lancet [J].
Al-Marzouki, Sanaa ;
Roberts, Ian ;
Evans, Stephen ;
Marshall, Tom .
LANCET, 2008, 372 (9634) :201-201
[2]   Registry of randomized controlled trials in transplantation [J].
Barcena, L ;
Pengel, L ;
Morris, PJ .
TRANSPLANTATION, 2005, 80 (11) :1525-1534
[3]   Bias in reporting clinical trials [J].
Bardy, AH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) :147-150
[4]  
BERLIN JA, 2005, INT J PHARM MED, V19, P277
[5]   Clinical research projects at a German medical faculty:: follow-up from ethical approval to publication and citation by others [J].
Bluemle, A. ;
Antes, G. ;
Schumacher, M. ;
Just, H. ;
von Elm, E. .
JOURNAL OF MEDICAL ETHICS, 2008, 34 (09) :e20
[6]  
BLUMLE A, 2009, 17 COCHR COLL SING, P49
[7]   Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov [J].
Bourgeois, Florence T. ;
Murthy, Srinivas ;
Mandl, Kenneth D. .
ANNALS OF INTERNAL MEDICINE, 2010, 153 (03) :158-U48
[8]   Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results [J].
Chan, An-Wen .
PLOS MEDICINE, 2008, 5 (11) :1533-1535
[9]   Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols [J].
Chan, An-Wen ;
Hrobjartsson, Asbjorn ;
Jorgensen, Karsten J. ;
Gotzsche, Peter C. ;
Altman, Douglas G. .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 :1404-1407
[10]  
Chan AW, 2005, CAN MED ASSOC J, V172, P857, DOI 10.1503/cmaj.1041723